Mimi I. Hu

6.2k total citations
117 papers, 3.3k citations indexed

About

Mimi I. Hu is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mimi I. Hu has authored 117 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Endocrinology, Diabetes and Metabolism, 57 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mimi I. Hu's work include Thyroid Cancer Diagnosis and Treatment (58 papers), Bone health and treatments (21 papers) and Bone and Joint Diseases (17 papers). Mimi I. Hu is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (58 papers), Bone health and treatments (21 papers) and Bone and Joint Diseases (17 papers). Mimi I. Hu collaborates with scholars based in United States, Italy and China. Mimi I. Hu's co-authors include Maria E. Cabanillas, Steven G. Waguespack, Camilo Jiménez, Robert F. Gagel, Naifa L. Busaidy, Ramona Dadu, Mouhammed Amir Habra, Anita K. Ying, Ana O. Hoff and Gabriel N. Hortobágyi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Mimi I. Hu

108 papers receiving 3.3k citations

Peers

Mimi I. Hu

ONCOL

EDM

OSM

SURGE

Sun Wook Cho South Korea

Sri Harsha Tella United States

Azeez Farooki United States

Theofanis Economopoulos Greece

Tetsuro Ishikawa Japan

Camilo Jiménez United States

J.J. Body Belgium

Christian Scheuba Austria

Judy Maddox United States

Philip J. Saylor United States

Sun Wook Cho South Korea

Mimi I. Hu

1.2k ×0.7

ONCOL

1.8k ×1.3

EDM

412 ×0.7

OSM

778 ×1.4

SURGE

1.4k ×2.5

Citations per year, relative to Mimi I. Hu Mimi I. Hu (= 1×) peers Sun Wook Cho

Countries citing papers authored by Mimi I. Hu

Since Specialization

Citations

This map shows the geographic impact of Mimi I. Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mimi I. Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mimi I. Hu more than expected).

Fields of papers citing papers by Mimi I. Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mimi I. Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mimi I. Hu. The network helps show where Mimi I. Hu may publish in the future.

Co-authorship network of co-authors of Mimi I. Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Mimi I. Hu. A scholar is included among the top collaborators of Mimi I. Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mimi I. Hu. Mimi I. Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salim, Hamza, Ahmed Msherghi, Kim O. Learned, et al.. (2025). Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis. Thyroid. 35(12). 1378–1390.

Hu, Mimi I., Roland L. Bassett, Anita K. Ying, et al.. (2024). Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2256–2268. 8 indexed citations

Brose, Marcia S., Bruce Robinson, Lori J. Wirth, et al.. (2024). Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC).. Journal of Clinical Oncology. 42(16_suppl). 11111–11111. 3 indexed citations

Hu, Mimi I., Yi‐Ju Chiang, Paul H. Graham, et al.. (2024). Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness. Journal of the Endocrine Society. 8(6). bvae048–bvae048. 8 indexed citations

Mulder, Michelle B., Hui Zhao, Kelly W. Merriman, et al.. (2024). The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?. Thyroid. 34(9). 1117–1125. 1 indexed citations

Mahvash, Armeen, et al.. (2024). Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases. JCEM Case Reports. 2(8). luae103–luae103. 1 indexed citations

Zhang, Chenyue, Zhitao Mao, Qianqian Yuan, et al.. (2024). Paradigm of engineering recalcitrant non-model microorganism with dominant metabolic pathway as a biorefinery chassis. Nature Communications. 15(1). 10441–10441. 14 indexed citations

Yedururi, Sireesha, Mimi I. Hu, Naifa L. Busaidy, et al.. (2024). Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma. Thyroid. 35(1). 6–17. 1 indexed citations

Hu, Mimi I., et al.. (2024). RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Annales d Endocrinologie. 85(2). 118–126. 2 indexed citations

10.

Fuleihan, Ghada El‐Hajj, Gregory A. Clines, Mimi I. Hu, et al.. (2022). Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 108(3). 507–528. 34 indexed citations

11.

Hoffman, Aubri, Maria E. Cabanillas, Julie Ann Sosa, et al.. (2021). Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid. JMIR Formative Research. 5(7). e27484–e27484. 5 indexed citations

12.

Hu, Mimi I., Steven G. Waguespack, Chrysoula Dosiou, et al.. (2021). Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 106(8). 2198–2207. 40 indexed citations

13.

Hu, Mimi I., Xiangyu Chen, Ju Huang, et al.. (2021). Revitalizing the ethanologenic bacterium Zymomonas mobilis for sugar reduction in high-sugar-content fruits and commercial products. Bioresources and Bioprocessing. 8(1). 119–119. 12 indexed citations

14.

Poznak, Catherine Van, Evan L. Reynolds, Cherry L. Estilo, et al.. (2020). Osteonecrosis of the jaw risk factors in bisphosphonate‐treated patients with metastatic cancer. Oral Diseases. 28(1). 193–201. 7 indexed citations

15.

Waguespack, Steven G., et al.. (2020). “Detecting the Undetectable”. Clinical Thyroidology. 32(1). 39–42. 2 indexed citations

16.

Maxwell, Jessica E., Maria Gule-Monroe, Vivek Subbiah, et al.. (2019). Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma. Surgery. 167(1). 80–86. 8 indexed citations

17.

Clayman, Gary L., Ian D. Hay, Mimi I. Hu, et al.. (2018). 88 ^th Annual Meeting of the American Thyroid Association. Thyroid. 28(S1). P–1. 6 indexed citations

18.

Xu, Jian, William A. Murphy, Denái R. Milton, et al.. (2016). Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 101(12). 4871–4877. 22 indexed citations

19.

Dadu, Ramona, Mimi I. Hu, Christina S. Baik, et al.. (2013). Aerodigestive Fistula Formation as a Rare Side Effect of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Thyroid Cancer. Thyroid. 24(5). 918–922. 74 indexed citations

20.

Hu, Mimi I., Robert F. Gagel, & Camilo Jiménez. (2007). Bone loss in patients with breast or prostate cancer. Current Osteoporosis Reports. 5(4). 170–178. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact